A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses

A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses

<b>Objective</b> Glioblastoma (GBM) is the most common primary malignant brain tumor regulated by numerous genes, with poor survival outcomes and unsatisfactory response to therapy. Therefore, a robust, multi-gene signature-derived model is required to predict the prognosis and treatment...

Full description

Bibliographic Details
Main Authors: Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang, Xiuwu Bian
Format: Article
Language:English
Published: China Anti-Cancer Association 2019-09-01
Series:Cancer Biology & Medicine
Subjects:
Differentially expressed genes
gene set enrichment analysis
glioblastoma prognosis
radiotherapy
temozolomide chemotherapy
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1457

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1457

Similar Items